Rebecca M Brotman1, Michelle D Shardell, Pawel Gajer, Doug Fadrosh, Kathryn Chang, Michelle I Silver, Raphael P Viscidi, Anne E Burke, Jacques Ravel, Patti E Gravitt. 1. From the 1Institute for Genome Sciences and 2Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD; 3Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Departments of 4Pediatrics and Neurovirology and 5Obstetrics and Gynecology, Johns Hopkins School of Medicine, Baltimore, MD; and 6Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD.
Abstract
OBJECTIVE: The vaginal microbiota helps protect the female genital tract from disease. We sought to describe the composition of the vaginal microbiota in premenopausal, perimenopausal, and postmenopausal women and to explore the association between the microbiota and vulvovaginal atrophy (VVA). METHODS: Eighty-seven women (aged 35-60 y) were classified as premenopausal (n = 30), perimenopausal (n = 29), or postmenopausal (n = 28) according to Stages of Reproductive Aging Workshop guidelines. Midvaginal bacterial community composition was characterized by 16S ribosomal RNA gene analysis. RESULTS: Bacterial communities clustered into six community state types (CSTs), of which four were dominated by Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus iners, or Lactobacillus jensenii, and two (CST IV-A and CST IV-B) had low relative abundance of Lactobacillus. CST IV-A was characterized by Streptococcus and Prevotella, whereas CST IV-B was characterized by Atopobium. There were significant associations between menopause stage and CST (P = 0.004) and between VVA and CST (P = 0.002). Perimenopausal women were more likely to be classified as CST IV-A or L. gasseri CST, whereas postmenopausal women were often classified as CST IV-A. CSTs dominated by L. crispatus and L. iners were more prevalent in premenopausal women. Nineteen participants had signs of mild or moderate VVA. Compared with women with no VVA, the vaginal microbiota of women with mild or moderate atrophy had 25-fold greater odds of being classified as CST IV-A versus L. crispatus CST (adjusted odds ratio, 25.89; 95% credible interval, 2.98-406.79). CONCLUSIONS: A distinct bacterial community state (CST IV-A) with a low relative abundance of Lactobacillus is associated with VVA. Future studies recruiting a larger number of women are needed to replicate the findings. This study provides an impetus for future longitudinal studies designed to manage, modulate, and restore vaginal microbiota homeostasis, which would provide stronger evidence for a causal relationship with VVA and ultimately improve the treatment and prevention of atrophic vaginitis in menopause.
OBJECTIVE: The vaginal microbiota helps protect the female genital tract from disease. We sought to describe the composition of the vaginal microbiota in premenopausal, perimenopausal, and postmenopausal women and to explore the association between the microbiota and vulvovaginal atrophy (VVA). METHODS: Eighty-seven women (aged 35-60 y) were classified as premenopausal (n = 30), perimenopausal (n = 29), or postmenopausal (n = 28) according to Stages of Reproductive Aging Workshop guidelines. Midvaginal bacterial community composition was characterized by 16S ribosomal RNA gene analysis. RESULTS: Bacterial communities clustered into six community state types (CSTs), of which four were dominated by Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus iners, or Lactobacillus jensenii, and two (CST IV-A and CST IV-B) had low relative abundance of Lactobacillus. CST IV-A was characterized by Streptococcus and Prevotella, whereas CST IV-B was characterized by Atopobium. There were significant associations between menopause stage and CST (P = 0.004) and between VVA and CST (P = 0.002). Perimenopausal women were more likely to be classified as CST IV-A or L. gasseri CST, whereas postmenopausal women were often classified as CST IV-A. CSTs dominated by L. crispatus and L. iners were more prevalent in premenopausal women. Nineteen participants had signs of mild or moderate VVA. Compared with women with no VVA, the vaginal microbiota of women with mild or moderate atrophy had 25-fold greater odds of being classified as CST IV-A versus L. crispatus CST (adjusted odds ratio, 25.89; 95% credible interval, 2.98-406.79). CONCLUSIONS: A distinct bacterial community state (CST IV-A) with a low relative abundance of Lactobacillus is associated with VVA. Future studies recruiting a larger number of women are needed to replicate the findings. This study provides an impetus for future longitudinal studies designed to manage, modulate, and restore vaginal microbiota homeostasis, which would provide stronger evidence for a causal relationship with VVA and ultimately improve the treatment and prevention of atrophic vaginitis in menopause.
Authors: Jacques Ravel; Pawel Gajer; Zaid Abdo; G Maria Schneider; Sara S K Koenig; Stacey L McCulle; Shara Karlebach; Reshma Gorle; Jennifer Russell; Carol O Tacket; Rebecca M Brotman; Catherine C Davis; Kevin Ault; Ligia Peralta; Larry J Forney Journal: Proc Natl Acad Sci U S A Date: 2010-06-03 Impact factor: 11.205
Authors: Pamina M Gorbach; Robert E Weiss; Edward Fuchs; Robin A Jeffries; Marjan Hezerah; Stephen Brown; Alen Voskanian; Edward Robbie; Peter Anton; Ross D Cranston Journal: Sex Transm Dis Date: 2012-01 Impact factor: 2.830
Authors: Ryan Rampersaud; Paul J Planet; Tara M Randis; Ritwij Kulkarni; Jorge L Aguilar; Robert I Lehrer; Adam J Ratner Journal: J Bacteriol Date: 2010-12-17 Impact factor: 3.490
Authors: Rebecca M Brotman; Mark A Klebanoff; Tonja R Nansel; Kai F Yu; William W Andrews; Jun Zhang; Jane R Schwebke Journal: J Infect Dis Date: 2010-11-10 Impact factor: 5.226
Authors: Patti E Gravitt; Anne F Rositch; Michelle I Silver; Morgan A Marks; Kathryn Chang; Anne E Burke; Raphael P Viscidi Journal: J Infect Dis Date: 2012-12-12 Impact factor: 5.226
Authors: Yuko M Komesu; Holly E Richter; Darrell L Dinwiddie; Nazema Y Siddiqui; Vivian W Sung; Emily S Lukacz; Beri Ridgeway; Lily A Arya; Halina M Zyczynski; Rebecca G Rogers; Marie Gantz Journal: Int Urogynecol J Date: 2016-10-13 Impact factor: 2.894
Authors: Krystal J Thomas-White; Stephanie Kliethermes; Leslie Rickey; Emily S Lukacz; Holly E Richter; Pamela Moalli; Philippe Zimmern; Peggy Norton; John W Kusek; Alan J Wolfe; Linda Brubaker Journal: Am J Obstet Gynecol Date: 2016-08-04 Impact factor: 8.661
Authors: William L Smith; Spencer R Hedges; Eli Mordechai; Martin E Adelson; Jason P Trama; Scott E Gygax; Andrew M Kaunitz; David W Hilbert Journal: J Clin Microbiol Date: 2014-06-04 Impact factor: 5.948
Authors: Caroline M Mitchell; Sujatha Srinivasan; Anna Plantinga; Michael C Wu; Susan D Reed; Katherine A Guthrie; Andrea Z LaCroix; Tina Fiedler; Matthew Munch; Congzhou Liu; Noah G Hoffman; Ian A Blair; Katherine Newton; Ellen W Freeman; Hadine Joffe; Lee Cohen; David N Fredricks Journal: Menopause Date: 2018-05 Impact factor: 2.953